I’ve bought this stock because it provides a solution to an urgent health problem. Getting autism diagnosis is a costly and difficult
problem and an early screening tool with sensitivity and specificity around 85% is really good. My question is if the research is all based in the US why has it been listed on the ASX and not US based stock exchange? Is it due to Brian Leedman?
Ann: Investor Presentation, page-14
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BB1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $12.27M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 20.5¢ | $49.43K | 234.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 119760 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 7876 | 1 |
View Market Depth
| Last trade - 15.57pm 30/08/2024 (20 minute delay) ? |
| BB1 (ASX) Chart |